4.5 Article

Neuroprotective effects of cyanidin against Aβ-induced oxidative and ER stress in SK-N-SH cells

Journal

NEUROCHEMISTRY INTERNATIONAL
Volume 101, Issue -, Pages 15-21

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuint.2016.09.016

Keywords

Alzheimer's disease; Cyanidin; Endoplasmic reticulum stress; Reactive oxygen species; Neuronal cells

Funding

  1. Faculty of Medicine Research Fund
  2. Thailand Research Fund [DBG5980003]
  3. Faculty of Medicine, Chiang Mai University, Thailand
  4. Graduate School, Chiang Mai University, Thailand

Ask authors/readers for more resources

This study evaluated the mechanisms underlying the protective effect of cyanidin against A beta(25-35)-induced neuronal cell death in SK-N-SH cells. A beta(25-35)-induced neurotoxicity is characterized by a decrease in cell viability, inducing the expression of endoplasmic reticulum (ER) stress proteins; an increase in intracellular reactive oxygen species (ROS) production; and an increase in intracellular calcium release. A beta(25-35) also induces neuronal toxicity through the disturbance of ER calcium levels. Pretreatment with cyanidin significantly attenuated the A beta(25-35)-induced loss of cell viability, reducing the expression of endoplasmic reticulum (ER) stress response proteins with regard to the down-regulation of the expression levels of 78 kDa glucose regulated protein (Grp78), phosphorylated forms of pancreatic ER eIF2 alpha kinase (PERK), eukaryotic initiation factor 2 alpha (eIF2 alpha), and inositol-requiring enzyme 1 (IRE1), and the expression levels of X-box binding protein 1 (XBP-1), activating transcription factor 6 (ATF6), and CCAAT/enhancer binding protein homologous transcription factor (C/EBP) homologous protein (CHOP); decreased intracellular ROS production; decreased intracellular calcium release; and reduced down regulation of the protein expression levels of calpain and cleaved caspase-12. This result suggests that cyanidin may be an alternative agent in preventing neurodegenerative diseases. (C) 2016 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available